Axe Compute Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire · 4 days ago
Axe Compute Signs Penguin Solutions as Strategic Partner to Accelerate Delivery of Next-Generation AI Infrastructure as Demand for Axe Compute Build SurgesGlobeNewsWire · Oct 14, 2026
Axe Compute Takes Full Ownership of Georgia AI Cluster, Significantly Increasing the Contract's Expected Free Cash Flow and Gross MarginGlobeNewsWire · Oct 5, 2026
Axe Compute Receives More Than $184 Million in Customer Prepayments and Signs Over $266 Million in New AI Infrastructure Contracts Since Q2 Earnings CallGlobeNewsWire · Sep 29, 2026
Is Axe Compute Inc (AGPU) Overvalued After 6.5% Rally? GF Value Says OvervaluedGuruFocus · Sep 25, 2026
DataMEDS AI Stock Surges Wednesday: What's Driving the Action?Benzinga · Sep 16, 2026Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 14, 2026 | – | -$0.87 | |
| May 15, 2026 | – | -$0.36 | |
| Mar 31, 2026 | $0.01 | $1.15 | Beat |
| Nov 14, 2025 | -$1.35 | -$4.52 | Miss |
| Aug 14, 2025 | -$1.35 | -$3.30 | Miss |
| May 15, 2025 | -$1.35 | -$4.80 | Miss |